Navigation Links
MedX Health Receives CE Mark for Laser & Light Products
Date:3/4/2009

MedX Expects Accelerated Revenue Growth From World's Largest Economy

MISSISSAUGA, ON, March 4 /PRNewswire-FirstCall/ - MedX Health Corp., (TSXV.MDX) a global leader in developing drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, today announced that the company has received CE Mark approval to market and sell the family of MedX laser and light products in all 25 European Union (EU) and three European Free Trade Association Member (EFTA) states. The CE Mark certifies that the MedX laser and light products have met EU health, safety and environmental requirements that ensure consumer and workplace safety.

"The CE Mark approval allows MedX to establish its global presence beyond North America, and further validates the benefits delivered through our non-invasive, drug-free products," states Steve Guillen, president and CEO of MedX Health. "This announcement comes shortly after achieving the International Organization of Standardization (ISO) re-certification, demonstrating to outside regulatory bodies that the highest quality standards are in place at MedX."

MedX continues to build upon its 10+ years of success in North America of bringing symptom relief in a non-pharmacologic manner to the rehabilitation/chiropractic/sports medicine markets. Through a rapidly growing international distributor network, which now includes the European Union, one of the largest and fastest growing markets in the world, MedX intends to expand its global reach and increase its revenue stream. Strong patent protection as well as developing and commercializing advanced products in the dental and wound care markets will also help position the company to increase revenues around the world. MedX presently holds key patents on its technology, and has received FDA clearance, Health Canada, and now the CE Mark on the family of laser and light products.

About MedX

MedX Health is a global leader in the design, manufacturing and distribution of quality low level laser and light therapy technology for use in numerous medical settings that provide patients with non-invasive, drug-free solutions for improving clinical outcomes. MedX's innovative Laser/Light Therapy devices enhance the patient's quality of life and improve the standard of care for tissue repair and pain relief.

MedX is expanding its distribution network and marketing programs globally through strategic partnerships, while continuing to develop and acquire new dental, rehabilitation and wound care products. In particular, MedX plans to accelerate the development of a new product aimed at the rapidly-growing wound care market. Recently, MedX announced a new patent allowance for bone growth that will join several key existing patents, including "Photobandage" a new technology that allows a wound to be bathed in light and is designed to enhance the healing process. The Company intends to license its proprietary wound care technologies to one or more major wound care companies for further development, marketing and commercialization.

    The TSX Venture Exchange does not accept responsibility for the adequacy
    or accuracy of this press release.

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. Such forward-looking information may include statements regarding the Company's future plans, objectives, performance, growth, profits, operating expenses or its underlying assumptions. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "does not anticipate", or "believes" or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", or "will be taken", "occur", or "be achieved". Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of MedX to be materially different from those expressed or implied by such forward-looking information, including uncertainty of successful development of new products, uncertainty of successful manufacturing or marketing of products, uncertainty of commercial acceptance of products, uncertainty concerning governmental regulation, dependency on key employees and relationships, rapid technological changes, foreign currency fluctuations. MedX does not undertake to update any forward-looking information, except in accordance with applicable securities laws.


'/>"/>
SOURCE MedX Health Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Shape Partners With Iams to Create Healthy Living Program Walk Your Dog, Make Life Better
2. AMERIGROUP Corporation to Present at the Barclays Capital Global Healthcare Conference on March 10
3. AAHSA Statement on Senate Special Committee on Aging Hearing, Health Reform in an Aging America
4. Health Strategies & Solutions Diagnoses Trends and Implications for Healthcare Industry in 2009 and Beyond
5. BioMarin to Present at the Barclays Capital Global Healthcare Conference
6. AFGE Congratulates Health and Human Services Secretary-designate Kathleen Sebelius
7. Lifeclinic International to Acquire Controlling Interest in My Health Rewards
8. Health Integrated Enjoys Steady Growth
9. Renaissance Health Systems Establishes Strategic Alliance for Staffing Solutions to Healthcare Providers
10. Career Step Launches New Training Program for Careers in Secure Healthcare Industry
11. HealthYes! Now Offering its Preventive Health Screening Services in Houston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter President, Joette ... the Pet Life Radio network. The episode, which was posted this week, features ... what factors led to Park Cities Pet Sitter’s being awarded the 2017 National Association ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... kept pace. Enovate Medical has introduced an innovative workstation designed to reduce nursing ... nurses, the Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative ...
(Date:2/17/2017)... Falls Church, VA (PRWEB) , ... ... ... to Integrate FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. ... , What are the critical reimbursement questions manufacturers should be asking ...
(Date:2/17/2017)... Sulphur Springs, Texas (PRWEB) , ... February 17, ... ... Electronic Signature 8.0 at the HIMSS17 Conference & Exhibition in Orlando, Fla., February ... the latest version of the most widely used electronic patient signatures solution ...
(Date:2/17/2017)... (PRWEB) , ... February 17, 2017 , ... ... their Chief Executive Officer, George Rogers, was named to Staffing Industry Analysts' 2017 ... Staffing 100 honors those who have made notable contributions to the staffing industry ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:2/17/2017)... ST. LOUIS , Feb. 17, 2017   ... hospitals, has announced a new partnership with Engage ... the United States . FormFast will serve ... part of Engage,s implementations with MEDITECH .  ... that provides essential functionality to complement and enhance the ...
(Date:2/17/2017)... 2017  Noble Capital Markets announced today that it ... EPIX ). The report was issued by ... PhD. ESSA Pharmaceuticals is a clinical stage ... (CRPC). Its lead compound EPI-506, is a small molecule ... the androgen receptor, thereby has potential to overcome some ...
Breaking Medicine Technology: